HIV and Women

NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding
Find information from OAR about NIH HIV/AIDS research priorities and guidelines for allocation of HIV funding for fiscal years 2021–2025.

NIH-Wide Strategic Plan for Research on the Health of Women
Find information from ORWH about the NIH vision for women’s health research.

Consideration of Sex as a Biological Variable in NIH-Funded Research
This NIH notice outlines the expectation that sex as a biological variable will be factored into research designs, analyses, and reporting in vertebrate animal and human studies.

• NIH Policy on Sex as a Biological Variable (ORWH)
  Read more about the NIH policy on the use of sex as a biological variable.

Inclusion of Women and Minorities as Participants in Research Involving Human Subjects
Read about the NIH policy that requires the inclusion of women and members of racial and ethnic minority groups in all NIH-funded clinical research.

Women & HIV Symposium: Considerations from Across the Lifespan
Read the Executive Summary of a February 2023 symposium, sponsored by OAR and ORWH, during the 13th International Workshop on HIV and Women. The symposium highlighted key HIV-related issues affecting women across the lifespan and identified priorities related to women, HIV, aging, and multimorbidity to inform a future research agenda.

Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV
This federally approved clinical practice guideline provides guidance on antiretroviral treatment in adults and adolescents, with sections on special populations, including women with HIV.

• Recommendations for Women with HIV

Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States
This federally approved clinical practice guideline provides guidance on antiretroviral treatment during pregnancy and addresses issues such as HIV testing and use of pre-exposure prophylaxis (PrEP) during pregnancy, prenatal and postnatal care for women with HIV, and breastfeeding for women with HIV.

• Update to Clinical Guidelines for Infant Feeding Supports Shared Decision-Making: Clarifying Breastfeeding Guidance for People with HIV

ClinicalTrials.gov trials on HIV and AIDS
Find clinical trials on HIV and AIDS around the world that are publicly and privately funded.

HIVinfo HIV Source
This portal provides English- and Spanish-language resources on HIV from within and outside the federal government.

HIVinfo HIV Fact Sheets
These fact sheets provide an overview of HIV, as well as information on HIV prevention, treatment, HIV and pregnancy, side effects of HIV medicines, and other topics related to living with HIV.

Clinicalinfo Drug Database  
The Drug Database provides information on HIV-related drugs, including FDA-approved antiretroviral and opportunistic infection drugs, as well as investigational drugs.

HIV.gov

•  HIV and Women's Health Issues

U.S. Department of Health and Human Services Office on Women’s Health

• Women and HIV

U.S. Food and Drug Administration

• Women and HIV: Get the Facts on HIV Testing, Prevention, and Treatment

This list of notice of funding opportunities (NOFOs) may include HIV receipt dates, which can differ from standard grant application due dates. Please note that some NOFOs allow HIV applications but may have specific requests, such as a requirement that all aims be related to HIV research. Contact the program officer indicated in the individual NOFO to request further details.

Articles

NIH Symposium Launches OAR-ORWH Partnership to Advance Research on HIV and Women Across the Lifespan
OAR Director’s Blog
The HIV and Women Signature Program was publicly launched during a symposium, sponsored by OAR and ORWH, at the 13th International Workshop on HIV & Women that highlighted innovative, multidisciplinary research aimed at addressing the health of women with or affected by HIV.

NIH OAR Marks 35 Years of Advancing HIV Research
OAR Director’s Blog
The NIH HIV research program has contributed groundbreaking innovations in HIV prevention, treatment, and cure. Among other breakthroughs, NIH clinical research has nearly eliminated perinatal HIV transmission.

Research Is Changing the Face of HIV for Women and Girls
OAR Director’s Blog
Women with or vulnerable to HIV need tailored HIV prevention, treatment, and cure research. NIH policies, resources for investigators, and targeted research funding are helping to ensure women and girls will benefit from HIV research.

New research findings show long-acting injectable regimen prevents HIV acquisition in women
OAR Director’s Blog
The HPTN 084 study demonstrated that the long-acting injectable cabotegravir is effective in preventing HIV acquisition among women. The promising results provide a new pathway for women to reduce their risk of HIV.

Videos

Using Primary Cell Model Systems to Evaluate the Role of Biological Sex in HIV Latency and Cure Strategies
Sex and Gender in Health and Disease Scientific Interest Group Webinar
Alberto Bosque, Ph.D., M.B.A., George Washington University School of Medicine and Health Sciences
ORWH, June 2021
This virtual talk discusses the basic mechanisms underlying HIV latency establishment and reversal required to develop successful HIV cure interventions.